Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Nov 14, 2024
- Accession no.
- 0001447362-24-000183
- Filed
- Nov 14, 2024
- Trade date
- Nov 12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions. Open-market sales total $175.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | Common Stock | SSaleDisposed | −1,972 | $34.15F2 | −$67,343.8 | 87,720 | Direct | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −1,010 | $34.15F2 | −$34,491.5 | 74,616 | Indirect | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −948 | $34.15F2 | −$32,374.2 | 63,891 | Indirect | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −300 | $34.15F2 | −$10,245 | 6,160 | Indirect | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −299 | $34.15F2 | −$10,210.85 | 6,151 | Indirect | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −299 | $34.15F2 | −$10,210.85 | 6,151 | Indirect | |
| Nov 12, 2024 | Common Stock | SSaleDisposed | −299 | $34.15F2 | −$10,210.85 | 6,151 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $33.81 to $34.51, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.